• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS T4 ASSAY; RADIOIMMUNOASSAY, TOTAL THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS T4 ASSAY; RADIOIMMUNOASSAY, TOTAL THYROXINE Back to Search Results
Catalog Number 07027885190
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/08/2021
Event Type  malfunction  
Event Description
The initial reporter complained of discrepant high results for 1 patient sample tested for elecsys t3 (t3), elecsys t4 assay (t4), roche elecsys anti-tg (anti-tg) and roche diagnostics cobas elecsys anti-tpo (anti-tpo) on 2 cobas e801 modules and a cobas 6000 e 601 module compared to an immusystem analyzer and an abbott analyzer.This medwatch will cover t4.Refer to medwatch with patient identifier (b)(6) for information on the t3 results, medwatch with patient identifier (b)(6) for information on the anti-tg results and medwatch with patient identifier (b)(6) for information on the anti-tpo results.Refer to attached data for the patient results.Questionable results were reported outside of the laboratory.The customer¿s e801 module serial number was (b)(4).The serial numbers for the e601 module and the e801 module used at the different laboratories were not provided.The reagent lot numbers used with the e601 module and the e801 module used at the other laboratories were not provided.
 
Manufacturer Narrative
The sample was requested for investigation.
 
Manufacturer Narrative
The sample was submitted for investigation.The results generated at the customer site for both the e801 and e601 modules were reproduced during the investigation.Upon investigation of the patient sample, an interferent against the streptavidin component of the reagent was confirmed.This caused the high results for t4, t3, anti-tpo and anti-tg as well as the different results between the e801 module and the e601 modules.Product labeling states: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design.For diagnostic purposes, the results should always be assessed in conjunction with the patient¿s medical history, clinical examination and other findings." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS T4 ASSAY
Type of Device
RADIOIMMUNOASSAY, TOTAL THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key12917305
MDR Text Key287422907
Report Number1823260-2021-03563
Device Sequence Number1
Product Code CDX
UDI-Device Identifier04015630939800
UDI-Public04015630939800
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K961490
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 02/14/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2022
Device Catalogue Number07027885190
Device Lot Number495851
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/11/2021
Initial Date FDA Received12/02/2021
Supplement Dates Manufacturer Received01/20/2022
Supplement Dates FDA Received02/14/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-